Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

HKG/2592 stock hub

HKG/2592 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

HKG/2592is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.3B

Hong Kong Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

HKG/2592

In the news

Latest news · HKG/2592

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC-139

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All HKG/2592 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

151

Groups with data

Currency

USD

Showing 151 of 151 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Cayman Islands
Country code	HK
Employees	61
Employees Change	10%
Employees Change Percent	19.61
Enterprise value	HKD 835.5M
Exchange	Hong Kong Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	HKD 1.3B
Price	HKD 1.52
Price currency	HKD
Rev Per Employee	32,282.13x
Sic	2836
Symbol	hkg/2592
Website	https://cloudbreakpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-41.02%
EV Earnings	-1.59x
EV/FCF	-2.07x
FCF yield	-31.37%
P/B ratio	2.73x
P/S ratio	651.91x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	100%
Gross Profit	HKD 2M
Gross Profit Growth	-97.53%
Gross Profit Growth Q	-97.8%
Gross Profit Growth3 Y	-18.71%
Net Income	HKD -526.6M
Pretax Margin	-26,788.15%
Profit Per Employee	HKD -8.6M
ROA	-125.7
ROCE	-176.9
ROIC	-139

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Revenue Growth	-97.52x
Revenue Growth Q	-97.8x
Revenue Growth3 Y	-18.71x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	HKD 0
Assets	HKD 518.4M
Cash	HKD 454.2M
Current Assets	HKD 503.9M
Current Liabilities	HKD 47.2M
Debt	HKD 5.9M
Debt Equity	HKD 0.01
Debt FCF	HKD -0.01
Equity	HKD 470.8M
Interest Coverage	-4,660
Liabilities	HKD 47.6M
Long Term Assets	HKD 14.6M
Long Term Liabilities	HKD 473,059
Net Cash	HKD 448.2M
Net Cash By Market Cap	HKD 34.92
Net Debt Equity	HKD -0.95
Tangible Book Value	HKD 470.8M
Tangible Book Value Per Share	HKD 0.56

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	10.68
Net Working Capital	HKD 4.9M
Quick ratio	10.09
Working Capital	HKD 453.9M
Working Capital Turnover	HKD -0.01

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-38.15%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
200-day SMA	4.02
50-day SMA	1.78
50-day SMA vs 200-day SMA	50under200
All Time High	9.74
All Time High Change	-84.39%
All Time High Date	2025-07-03
All Time Low	1.26
All Time Low Change	20.63%
All Time Low Date	2026-04-16
ATR	0.14
Beta1y	0.32
Ch YTD	-70.77
High	1.6
High52	9.74
High52 Date	2025-07-03
High52ch	-84.39%
Low	1.46
Low52	1.26
Low52 Date	2026-04-16
Low52ch	20.64%
Ma50ch	-14.65%
Price vs 200-day SMA	-62.18%
RSI	44.95
RSI Monthly	0
RSI Weekly	32.39
Sharpe ratio	-1.5x
Sortino ratio	-1.91
Total Return	-38.15%
Tr YTD	-70.77
Tr1m	-11.11%
Tr1w	2.01%
Tr3m	-32.74%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	HKD -834.2M
Operating margin	-42,363.2

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	303,620,131%
Net Borrowing	971,112.2
Shares Insiders	41.32%
Shares Out	844,565,892
Shares Qo Q	7.99%
Shares Yo Y	38.15%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	HKD -852.4M
Average Volume	1,628,850x
Bv Per Share	0.56
CAPEX	HKD -1.5M
Ch1m	-11.11
Ch1w	2.01
Ch3m	-32.74
Ch6m	-66.88
Change	-3.18%
Change From Open	-3.18
Close	1.57
Days Gap	0
Depreciation Amortization	2,067,529.2
Dollar Volume	430,160
Earnings Date	2026-05-29
EBIT	HKD -834.2M
EBITDA	HKD -832.2M
EPS	HKD -0.8
F Score	2
FCF	HKD -402.7M
FCF EV Yield	-48.2x
FCF Per Share	HKD -0.48
Financing CF	573,071,337
Fiscal Year End	December
Founded	2,015
Income Tax	HKD -887,312
Investing CF	-132,832,187
Is Primary Listing	1
Last Earnings Date	2026-03-30
Last Report Date	2025-12-31
Ma150	3.61
Ma150ch	-57.94%
Ma20	1.51
Ma20ch	0.6%
Net CF	41,158,831
Next Earnings Date	2026-05-29
Open	1.57
Position In Range	42.86
Ppne	17,417,367.2
Price Date	2026-05-08
Ptbv Ratio	2.73
Relative Volume	0.17x
Revenue	1,969,210x
SBC By Revenue	22,839.53x
Share Based Comp	449,758,297
Tax By Revenue	-45.06x
Tr6m	-66.88%
Volume	283,000
Z Score	43.96

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does HKG/2592 pay a dividend?

Capital-return profile for this ticker.

Ownership

Who owns HKG/2592?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+41.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+38.1%

Negative means the company is buying back shares.

Technical

HKG/2592 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

45.0

Neutral momentum band

Price vs 200-day MA

-62.2%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-1.50

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About HKG/2592

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hkg/2592 stock rating?

hkg/2592 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hkg/2592 analysis?

The full report lives at /stocks/hkg/2592/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hkg/2592?

The latest report frames hkg/2592 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hkg/2592 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.